Novagold Resources Inc. · AMEX:NG
Novagold Resources — Q1 2025 Earnings Presentation
12 slides from Novagold Resources's earnings presentation, Apr 1, 2025
Slide 1: First Quarter 2025 Earnings Conference Call
First Quarter 2025 May 1, 2025 Earnings Conference Call J. David Joyner Thomas F. Cowhey President and Executive Vice President and Chief Executive Officer Chief Financial Officer 1 ©2025 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 2: Cautionary Statement concerning forward-looking statements
Cautionary Statement concerning forward-looking statements This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation (“CVS Health”). By their nature,
Slide 3: Enterprise Highlights
Enterprise Highlights Delivered consolidated revenue growth of 7.0% and adjusted EPS of $2.25 in the first quarter of 2025. Raised 2025 adjusted EPS guidance to a range of $6.00 to $6.20. Delivering better experiences that First Quarter Full Year 2025 Build Trust Financial Results Company Guidance I
Slide 4: Becoming America's most trusted health care company
OUR FOCUS Becoming America’s most trusted health care company 4 ©2025 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 5: Strategic Imperatives
Strategic Imperatives Grow our core business Build diverse national care delivery and value-based care capabilities Enable consumers’ health with care and coverage capabilities across local points of care Create seamless engagement and personalized experiences across all company channels Empower our
Slide 6: Consolidated Results
Consolidated Results Quarter Results 1Q 2025 1Q 2024 In billions, except per share amounts Business highlights Total Revenues $94.6 $88.4 Ongoing portfolio management through our decision to exit the states in which Aetna independently Adjusted Operating Income $4.58 $2.96 operates Individual ACA pl
Slide 7: Consolidated Guidance
Consolidated Guidance Full Year Guidance Full Year 2025 Full Year 2025 In billions, except per share amounts and tax rate as of May 1, 2025 as of February 12, 2025 Business highlights Total Revenues At least $382.6 At least $385.9 Revised total revenues to at least $382.6 billion, down ~$3.3 billion
Slide 8: Superior assets. Superior care. Superior value.
Superior assets. Superior care. Superior value. 8 ©2025 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 9: Health Care Benefits
Health Care Benefits Quarter Results 1Q 2025 1Q 2024 Business highlights In billions, except MBR and membership Total Revenues $34.8 $32.2 First quarter adjusted operating income Adjusted Operating Income $1.99 $0.73 increased by over $1.2 billion year-over- year, driven by the favorable impact of T
Slide 10: Health Services
Health Services Quarter Results 1Q 2025 1Q 2024 Business highlights In billions, except pharmacy claims Total Revenues $43.5 $40.3 First quarter adjusted operating income increased ~18% year over year, driven by improved purchasing economics and pharmacy drug mix, partially offset by Adjusted Operat
Slide 11: Pharmacy & Consumer Wellness
Pharmacy & Consumer Wellness Quarter Results 1Q 2025 1Q 2024 Business highlights In billions, except prescriptions filled Total Revenues $31.9 $28.7 First quarter adjusted operating income increased over 11% year over year, driven by increased prescription volume and improved drug purchasing, partia
Slide 12: Footnotes
Footnotes First Quarter 2025 1. Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. 2. Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company’s retail pharmacy stores that have been operati